 Andrew Nesterovitch
Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 3 | 2016 | 16 | 1.410 |
Why?
| | Mutation | 9 | 2016 | 464 | 1.200 |
Why?
| | Peptidyl-Dipeptidase A | 7 | 2016 | 7 | 1.090 |
Why?
| | Neutrophils | 3 | 2016 | 133 | 0.910 |
Why?
| | Skin Diseases | 2 | 2011 | 37 | 0.800 |
Why?
| | Sweet Syndrome | 1 | 2016 | 6 | 0.590 |
Why?
| | Lectins, C-Type | 2 | 2016 | 145 | 0.580 |
Why?
| | Pyoderma Gangrenosum | 1 | 2016 | 12 | 0.580 |
Why?
| | Interleukin-1beta | 1 | 2016 | 59 | 0.580 |
Why?
| | Immunity, Innate | 2 | 2016 | 97 | 0.570 |
Why?
| | Amino Acid Substitution | 3 | 2010 | 39 | 0.420 |
Why?
| | Hereditary Autoinflammatory Diseases | 1 | 2011 | 5 | 0.420 |
Why?
| | Base Sequence | 4 | 2013 | 166 | 0.340 |
Why?
| | Molecular Sequence Data | 6 | 2014 | 315 | 0.290 |
Why?
| | Animals | 10 | 2016 | 5312 | 0.260 |
Why?
| | Mice | 6 | 2016 | 1894 | 0.230 |
Why?
| | Cell Membrane | 3 | 2016 | 132 | 0.230 |
Why?
| | Mutant Proteins | 3 | 2011 | 9 | 0.230 |
Why?
| | Cricetulus | 5 | 2016 | 19 | 0.220 |
Why?
| | CHO Cells | 5 | 2016 | 24 | 0.220 |
Why?
| | Cricetinae | 4 | 2016 | 52 | 0.190 |
Why?
| | Mutagenesis, Site-Directed | 4 | 2011 | 29 | 0.170 |
Why?
| | Muramidase | 1 | 2016 | 2 | 0.150 |
Why?
| | Bilirubin | 1 | 2016 | 14 | 0.150 |
Why?
| | Peptides | 2 | 2016 | 116 | 0.150 |
Why?
| | Gene Expression Profiling | 2 | 2016 | 183 | 0.150 |
Why?
| | Mice, Inbred BALB C | 4 | 2011 | 296 | 0.150 |
Why?
| | Toll-Like Receptors | 1 | 2016 | 34 | 0.140 |
Why?
| | Bone Marrow Cells | 1 | 2016 | 63 | 0.140 |
Why?
| | Protein Conformation | 3 | 2010 | 94 | 0.140 |
Why?
| | Cell Differentiation | 1 | 2016 | 174 | 0.140 |
Why?
| | Skin | 1 | 2016 | 136 | 0.140 |
Why?
| | Humans | 11 | 2016 | 31481 | 0.130 |
Why?
| | Up-Regulation | 1 | 2016 | 220 | 0.130 |
Why?
| | Heterozygote | 2 | 2013 | 115 | 0.130 |
Why?
| | Oligopeptides | 1 | 2014 | 34 | 0.130 |
Why?
| | Fibrosis | 1 | 2014 | 53 | 0.130 |
Why?
| | Pedigree | 2 | 2013 | 72 | 0.120 |
Why?
| | Antibodies, Monoclonal | 2 | 2016 | 301 | 0.120 |
Why?
| | Chromosome Mapping | 2 | 2011 | 46 | 0.120 |
Why?
| | DNA Mutational Analysis | 2 | 2011 | 73 | 0.120 |
Why?
| | Renin-Angiotensin System | 1 | 2013 | 9 | 0.120 |
Why?
| | Asymptomatic Diseases | 1 | 2013 | 21 | 0.120 |
Why?
| | Sequence Deletion | 1 | 2013 | 21 | 0.120 |
Why?
| | Transfection | 2 | 2010 | 154 | 0.120 |
Why?
| | Dendritic Cells | 1 | 2013 | 67 | 0.120 |
Why?
| | Blotting, Western | 2 | 2010 | 225 | 0.120 |
Why?
| | Signal Transduction | 1 | 2016 | 588 | 0.110 |
Why?
| | Recombinant Proteins | 2 | 2010 | 295 | 0.110 |
Why?
| | Proteolysis | 1 | 2011 | 20 | 0.110 |
Why?
| | Genetic Predisposition to Disease | 2 | 2005 | 462 | 0.110 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2011 | 10 | 0.100 |
Why?
| | Homozygote | 1 | 2011 | 28 | 0.100 |
Why?
| | Alternative Splicing | 1 | 2011 | 32 | 0.100 |
Why?
| | Immunoglobulins | 1 | 2011 | 35 | 0.100 |
Why?
| | Exons | 1 | 2011 | 46 | 0.100 |
Why?
| | Gene Deletion | 1 | 2011 | 57 | 0.100 |
Why?
| | Single-Chain Antibodies | 1 | 2010 | 1 | 0.100 |
Why?
| | Drug Carriers | 1 | 2010 | 8 | 0.100 |
Why?
| | Cytokines | 2 | 2011 | 364 | 0.100 |
Why?
| | Cloning, Molecular | 1 | 2010 | 47 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 191 | 0.100 |
Why?
| | Autoantibodies | 1 | 2011 | 119 | 0.100 |
Why?
| | Endothelial Cells | 1 | 2010 | 67 | 0.100 |
Why?
| | Adrenal Cortex Hormones | 1 | 2011 | 100 | 0.100 |
Why?
| | Gene Dosage | 1 | 2009 | 27 | 0.100 |
Why?
| | Cluster Analysis | 1 | 2009 | 55 | 0.090 |
Why?
| | Haplotypes | 1 | 2009 | 63 | 0.090 |
Why?
| | Lung | 1 | 2010 | 171 | 0.090 |
Why?
| | Mice, Inbred C57BL | 1 | 2011 | 548 | 0.090 |
Why?
| | Inflammation | 1 | 2011 | 360 | 0.090 |
Why?
| | Female | 7 | 2013 | 18253 | 0.080 |
Why?
| | Male | 6 | 2013 | 17583 | 0.080 |
Why?
| | Quantitative Trait Loci | 2 | 2005 | 66 | 0.080 |
Why?
| | Models, Molecular | 3 | 2011 | 99 | 0.070 |
Why?
| | Spondylarthropathies | 1 | 2005 | 9 | 0.070 |
Why?
| | Amino Acid Sequence | 3 | 2014 | 254 | 0.070 |
Why?
| | Proteoglycans | 2 | 2005 | 419 | 0.070 |
Why?
| | Protein Structure, Tertiary | 3 | 2011 | 82 | 0.070 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2003 | 36 | 0.060 |
Why?
| | Protein Binding | 2 | 2016 | 155 | 0.060 |
Why?
| | Arthritis | 1 | 2003 | 113 | 0.060 |
Why?
| | Extracellular Matrix Proteins | 1 | 2003 | 176 | 0.060 |
Why?
| | Cartilage | 1 | 2003 | 168 | 0.060 |
Why?
| | Arthritis, Experimental | 1 | 2003 | 139 | 0.050 |
Why?
| | Adult | 2 | 2013 | 9779 | 0.050 |
Why?
| | Temperature | 2 | 2010 | 85 | 0.050 |
Why?
| | Aged | 2 | 2013 | 10295 | 0.050 |
Why?
| | Middle Aged | 2 | 2013 | 11209 | 0.050 |
Why?
| | Hybridomas | 2 | 2010 | 21 | 0.040 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2016 | 1 | 0.040 |
Why?
| | Surface Plasmon Resonance | 1 | 2016 | 9 | 0.040 |
Why?
| | Sarcoidosis | 1 | 2016 | 15 | 0.040 |
Why?
| | Flow Cytometry | 1 | 2016 | 217 | 0.040 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2016 | 59 | 0.040 |
Why?
| | Phenotype | 1 | 2016 | 379 | 0.030 |
Why?
| | Mice, Inbred DBA | 2 | 2005 | 54 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2016 | 687 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2014 | 29 | 0.030 |
Why?
| | Kinetics | 1 | 2014 | 278 | 0.030 |
Why?
| | Captopril | 1 | 2013 | 2 | 0.030 |
Why?
| | Cell Line | 1 | 2014 | 360 | 0.030 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 31 | 0.030 |
Why?
| | Gene Expression | 1 | 2013 | 272 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2011 | 23 | 0.030 |
Why?
| | Computational Biology | 1 | 2011 | 31 | 0.030 |
Why?
| | Binding Sites | 1 | 2011 | 93 | 0.030 |
Why?
| | Blood Pressure | 1 | 2013 | 260 | 0.030 |
Why?
| | Endopeptidases | 1 | 2011 | 58 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2011 | 89 | 0.030 |
Why?
| | Complementarity Determining Regions | 1 | 2010 | 3 | 0.030 |
Why?
| | Epitope Mapping | 1 | 2010 | 3 | 0.030 |
Why?
| | Glycosylation | 1 | 2010 | 22 | 0.030 |
Why?
| | Protein Stability | 1 | 2010 | 11 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2010 | 54 | 0.030 |
Why?
| | Antibody Specificity | 1 | 2010 | 59 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 2010 | 45 | 0.020 |
Why?
| | Species Specificity | 1 | 2010 | 78 | 0.020 |
Why?
| | Disease Models, Animal | 2 | 2005 | 832 | 0.020 |
Why?
| | Protein Denaturation | 1 | 2010 | 4 | 0.020 |
Why?
| | Biocatalysis | 1 | 2010 | 3 | 0.020 |
Why?
| | Molecular Chaperones | 1 | 2010 | 14 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 148 | 0.020 |
Why?
| | Protein Transport | 1 | 2010 | 42 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2010 | 40 | 0.020 |
Why?
| | Family | 1 | 2010 | 111 | 0.020 |
Why?
| | Rats | 1 | 2010 | 966 | 0.020 |
Why?
| | Adolescent | 1 | 2013 | 2667 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2005 | 17 | 0.020 |
Why?
| | Crosses, Genetic | 1 | 2005 | 17 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2005 | 43 | 0.020 |
Why?
| | Genetic Markers | 1 | 2005 | 51 | 0.020 |
Why?
| | Cross Reactions | 1 | 2003 | 28 | 0.020 |
Why?
| | Immunization | 1 | 2003 | 50 | 0.020 |
Why?
| | Mice, SCID | 1 | 2003 | 64 | 0.020 |
Why?
| | Lod Score | 1 | 2003 | 15 | 0.020 |
Why?
| | X Chromosome | 1 | 2003 | 11 | 0.020 |
Why?
| | Adoptive Transfer | 1 | 2003 | 51 | 0.020 |
Why?
| | Hindlimb | 1 | 2003 | 31 | 0.020 |
Why?
| | Epitopes | 1 | 2003 | 92 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2003 | 87 | 0.010 |
Why?
| | Aggrecans | 1 | 2003 | 200 | 0.010 |
Why?
| | Joints | 1 | 2003 | 101 | 0.010 |
Why?
| | Incidence | 1 | 2005 | 829 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2003 | 242 | 0.010 |
Why?
| | Sex Factors | 1 | 2003 | 542 | 0.010 |
Why?
|
|
Nesterovitch's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|